Pro-Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 4.30 Cr
- Paid Up Capital ₹ 3.65 Cr
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.75 Cr
- Revenue Growth -25.08%
- Profit Growth 100.39%
- Ebitda 11.06%
- Net Worth 8.33%
- Total Assets -38.73%
About Pro-Pharma Care
Pro-Pharma Care Private Limited (PCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 November 2012 and has a history of 12 years and two months. Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.30 Cr and a paid-up capital of Rs 3.65 Cr.
The company currently has active open charges totaling ₹3.75 Cr.
Subhash Rijhwani and Yogesh Verma serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100UR2012PTC000458
-
Company No.
000458
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2012
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Pro-Pharma Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Rijhwani
|
Director | 07-Nov-2012 | Current |
|
Yogesh Verma
|
Director | 31-May-2017 | Current |
Financial Performance of Pro-Pharma Care.
Pro-Pharma Care Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.08% decrease. The company also saw a substantial improvement in profitability, with a 100.39% increase in profit. The company's net worth moved up by a moderate rise of 8.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pro-Pharma Care?
In 2023, Pro-Pharma Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Pure Pharma LimitedSubhash Rijhwani is a mutual person
-
Metfils Packaging Private LimitedSubhash Rijhwani is a mutual person
-
Promed Laboratories Private Limited
Subhash Rijhwani is a mutual person
-
Sahaj Ratan Charitable Foundation
Subhash Rijhwani is a mutual person
Charges (Loans)
₹3.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2014 | Axis Bank Limited | ₹3.75 Cr | Open |
How Many Employees Work at Pro-Pharma Care?
Unlock and access historical data on people associated with Pro-Pharma Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pro-Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pro-Pharma Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
